<VariationArchive VariationID="843472" VariationName="NM_025099.6(CTC1):c.3019del (p.Leu1007fs)" VariationType="Deletion" Accession="VCV000843472" Version="17" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-06-23" DateCreated="2020-04-15" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="846602" VariationID="843472">
      <GeneList>
        <Gene Symbol="CTC1" FullName="CST telomere replication complex component 1" GeneID="80169" HGNC_ID="HGNC:26169" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8224815" stop="8248056" display_start="8224815" display_stop="8248056" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="8128138" stop="8151412" display_start="8128138" display_stop="8151412" Strand="-" />
          </Location>
          <OMIM>613129</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025099.6(CTC1):c.3019del (p.Leu1007fs)</Name>
      <CanonicalSPDI>NC_000017.11:8229438:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8229439" stop="8229439" display_start="8229439" display_stop="8229439" variantLength="1" positionVCF="8229438" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="8132757" stop="8132757" display_start="8132757" display_stop="8132757" variantLength="1" positionVCF="8132756" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L1007fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.8132760del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.8132760del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.8229442del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.8229442del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032148.2" sequenceAccession="NG_032148" sequenceVersion="2" change="g.23657del">
            <Expression>NG_032148.2:g.23657del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025099.6" sequenceAccession="NM_025099" sequenceVersion="6" change="c.3019del" MANESelect="true">
            <Expression>NM_025099.6:c.3019del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079375.3" sequenceAccession="NP_079375" sequenceVersion="3" change="p.Leu1007fs">
            <Expression>NP_079375.3:p.Leu1007fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_046431.2" sequenceAccession="NR_046431" sequenceVersion="2" change="n.2934del">
            <Expression>NR_046431.2:n.2934del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1124" sequenceAccession="LRG_1124">
            <Expression>LRG_1124:g.23657del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1124t1" sequenceAccession="LRG_1124t1">
            <Expression>LRG_1124t1:c.3019del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1124p1" sequenceAccession="LRG_1124p1" change="p.Leu1007fs">
            <Expression>LRG_1124p1:p.Leu1007fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025099.6(CTC1):c.3019del (p.Leu1007fs) AND Dyskeratosis congenita" Accession="RCV001046110" Version="5">
        <ClassifiedConditionList TraitSetID="8154">
          <ClassifiedCondition DB="MedGen" ID="C0265965">Dyskeratosis congenita</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025099.6(CTC1):c.3019del (p.Leu1007fs) AND not provided" Accession="RCV001281622" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-08" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025099.6(CTC1):c.3019del (p.Leu1007fs) AND Cerebroretinal microangiopathy with calcifications and cysts 1" Accession="RCV001784596" Version="7">
        <ClassifiedConditionList TraitSetID="7901">
          <ClassifiedCondition DB="MedGen" ID="C4552029">Cerebroretinal microangiopathy with calcifications and cysts 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025099.6(CTC1):c.3019del (p.Leu1007fs) AND Coats plus syndrome" Accession="RCV004017780" Version="2">
        <ClassifiedConditionList TraitSetID="37117">
          <ClassifiedCondition DB="MedGen" ID="C2677299">Coats plus syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025099.6(CTC1):c.3019del (p.Leu1007fs) AND CTC1-related disorder" Accession="RCV003963008" Version="2">
        <ClassifiedConditionList TraitSetID="89984">
          <ClassifiedCondition>CTC1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-07" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2020-04-15" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22267198</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22387016</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23869908</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="89984" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69847" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CTC1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CTC1-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="37117" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="37893" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Coats plus syndrome</ElementValue>
                <XRef ID="320777" DB="GeneTests" />
                <XRef ID="MONDO:0012815" DB="MONDO" />
                <XRef ID="313838" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroretinal microangiopathy with calcifications and cysts</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CRMCC</ElementValue>
                <XRef Type="MIM" ID="612199" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17412" />
                <XRef ID="17412" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="313838" DB="Orphanet" />
              <XRef ID="C2677299" DB="MedGen" />
              <XRef ID="MONDO:0012815" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS612199" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7901" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1351" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebroretinal microangiopathy with calcifications and cysts 1</ElementValue>
                <XRef ID="Cerebroretinal+microangiopathy+with+calcifications+and+cysts/7948" DB="Genetic Alliance" />
                <XRef ID="MONDO:0024564" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CRMCC1</ElementValue>
                <XRef Type="MIM" ID="612199" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CRMCC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18441" />
                <XRef ID="18441" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="313838" DB="Orphanet" />
              <XRef ID="C4552029" DB="MedGen" />
              <XRef ID="MONDO:0024564" DB="MONDO" />
              <XRef Type="MIM" ID="612199" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8154" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15989" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita</ElementValue>
                <XRef ID="Dyskeratosis+congenita/9566" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015780" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
                <XRef ID="74911008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10905" />
                <XRef ID="10905" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="1775" DB="Orphanet" />
              <XRef ID="C0265965" DB="MedGen" />
              <XRef ID="MONDO:0015780" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2894860" SubmissionDate="2021-01-05" DateLastUpdated="2021-01-17" DateCreated="2021-01-17">
        <ClinVarSubmissionID localKey="BDX_WES_226bis|Not provided" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001468952" DateUpdated="2021-01-17" DateCreated="2021-01-17" Type="SCV" Version="1" SubmitterName="Laboratoire de Génétique Moléculaire, CHU Bordeaux" OrgID="506172" OrganizationCategory="laboratory" OrgAbbreviation="GenMol" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.5:c.3019del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8845514</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4028856" SubmissionDate="2022-01-10" DateLastUpdated="2022-01-12" DateCreated="2022-01-12">
        <ClinVarSubmissionID localKey="NM_025099.6:c.3019del|OMIM:612199" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002055619" DateUpdated="2022-01-12" DateCreated="2022-01-12" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.6:c.3019del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612199" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918493</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7167221" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="NM_025099.6(CTC1):c.3019del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003839403" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the CTC1 gene demonstrated a single base pair deletion in exon 19, c.3019del. This sequence change results in an amino acid frameshift and creates a premature stop codon 61 amino acids downstream of the change, p.Leu1007Cysfs*62. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated CTC1 protein with potentially abnormal function. This sequence change has been described in the gnomAD database with a frequency of 0.11% in the Finnish subpopulation and 0.019% in the overall population (dbSNP rs199473680). This pathogenic sequence change has previously been described in the compound heterozygous state in an individual with cerebroretinal microangiopathy with calcifications and cysts (PMID: 22387016). A functional study in mouse cDNA indicates that this sequence change causes loss-of-function (PMID: 23869908). These collective evidences indicate that this sequence change is pathogenic. This pathogenic sequence change in the heterozygous state is not sufficient to cause this individual’s phenotype.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.6:c.3019del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12941816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7549905" SubmissionDate="2023-09-13" DateLastUpdated="2023-09-16" DateCreated="2023-09-16">
        <ClinVarSubmissionID localKey="GDXSV:287147" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004034403" DateUpdated="2023-09-16" DateCreated="2023-09-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect: anomalous telomere replication (Gu et al., 2013); This variant is associated with the following publications: (PMID: 22387016, 23869908, 34308104)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:715566</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.5:c.3019del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_217_20230913054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7679890" SubmissionDate="2023-11-01" DateLastUpdated="2023-11-04" DateCreated="2023-11-04">
        <ClinVarSubmissionID localKey="4095354_NM_025099.6:c.3019del|OMIM:612199" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004100754" DateUpdated="2023-11-04" DateCreated="2023-11-04" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria applied: PVS1,PM2_SUP,PS3_SUP,PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001508" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0410018" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0007968" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008070" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001511" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008277" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001518" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000175" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001270" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.6:c.3019del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612199" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13946886</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3967784" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="c33bf090fc3c57f47e5ae27e5a661bb617c4c18b0fe0e1a41e4d7768cb3d4b54|OMIM:612199" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019762" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.5:c.3019del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612199" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2375303" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="177000|MedGen:C0265965" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001209998" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22267198</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22387016</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22387016</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu1007Cysfs*62) in the CTC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTC1 are known to be pathogenic (PMID: 22267198, 22387016). This variant is present in population databases (rs199473680, gnomAD 0.1%). This premature translational stop signal has been observed in individual(s) with cerebroretinal microangiopathy with calcifications and cysts (PMID: 22387016). ClinVar contains an entry for this variant (Variation ID: 843472). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.8132757del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265965" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8867254" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="15385312|CTC1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004780809" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CTC1 c.3019delC variant is predicted to result in a frameshift and premature protein termination (p.Leu1007Cysfs*62). This variant has been reported in the compound heterozygous state in an individual with cerebroretinal microangiopathy with calcifications and cysts (CRMCC), while the patient’s heterozygous father was unaffected (Polvi et al. 2012. PubMed ID: 22387016). Functional studies of mouse CTC1 p.L1002*, which is the equivalent to human CTC1 p.Leu1007Cysfs*62, showed that the variant lead to a disruption of CST complex formation, which is necessary for telomere replication (Gu et al. 2013. PubMed ID: 23869908). This variant is reported in 0.11% of alleles in individuals of European (Finnish) descent in gnomAD. Frameshift variants in CTC1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025099.5:c.3019delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CTC1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9057066" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="74225316|Orphanet:ORPHA313838" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848044" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23869908</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22387016</ID>
          </Citation>
          <Comment>The p.Leu1007CysfsX62 variant in CTC1 has been reported in 1 compound heterozygous, Finnish individual with clinical features of cerebroretinal microangiopathy with calcifications and cysts-1 (CRMCC1) (Polvi 2012). This variant has also been identified in 0.02% (13/66568) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs199473680). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 1007 and leads to a premature termination codon 62 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. In vitro and mouse model functional studies also provide evidence that the p.Leu1007CysfsX62 variant impacts protein function (Gu 2013). No individuals affected with CRMCC1 reported to date are compound heterozygous or homozygous for 2 null variants, suggesting that biallelic null mutations might be incompatible with development (Anderson 2012). In summary, this variant meets criteria to be classified as pathogenic for CRMCC1 in an autosomal recessive manner based upon case observation, functional evidence and low frequency in controls.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_025099.6:exon 19</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.8229439delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA313838" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008070" MappingRef="HP">
        <MedGen CUI="C5551005" Name="Sparse hair" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001518" MappingRef="HP">
        <MedGen CUI="C0235991" Name="Small for gestational age" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2375303" TraitType="Disease" MappingType="XRef" MappingValue="C0265965" MappingRef="MedGen">
        <MedGen CUI="C0265965" Name="Dyskeratosis congenita" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7549905" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3967784" TraitType="Disease" MappingType="XRef" MappingValue="612199" MappingRef="OMIM">
        <MedGen CUI="C4552029" Name="Cerebroretinal microangiopathy with calcifications and cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894860" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007968" MappingRef="HP">
        <MedGen CUI="C0266568" Name="Persistent hyperplastic primary vitreous" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000175" MappingRef="HP">
        <MedGen CUI="C2981150" Name="Cleft palate" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4028856" TraitType="Disease" MappingType="XRef" MappingValue="612199" MappingRef="OMIM">
        <MedGen CUI="C4552029" Name="Cerebroretinal microangiopathy with calcifications and cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008277" MappingRef="HP">
        <MedGen CUI="C4024711" Name="Abnormal blood zinc concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9057066" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA313838" MappingRef="Orphanet">
        <MedGen CUI="C2677299" Name="Coats plus syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0410018" MappingRef="HP">
        <MedGen CUI="C0743360" Name="Recurrent ear infections" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7167221" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001270" MappingRef="HP">
        <MedGen CUI="C1854301" Name="Motor delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001511" MappingRef="HP">
        <MedGen CUI="C0015934" Name="Fetal growth restriction" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001508" MappingRef="HP">
        <MedGen CUI="C2315100" Name="Failure to thrive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7679890" TraitType="Disease" MappingType="XRef" MappingValue="612199" MappingRef="OMIM">
        <MedGen CUI="C4552029" Name="Cerebroretinal microangiopathy with calcifications and cysts 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8867254" TraitType="Disease" MappingType="Name" MappingValue="CTC1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="CTC1-related disorder" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001521623</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

